Trident Texofab standalone net profit rises 3800.00% in the September 2022 quarter

Image
Capital Market
Last Updated : Oct 11 2022 | 2:16 PM IST

Sales rise 14.93% to Rs 24.17 crore

Net profit of Trident Texofab rose 3800.00% to Rs 0.78 crore in the quarter ended September 2022 as against Rs 0.02 crore during the previous quarter ended September 2021. Sales rose 14.93% to Rs 24.17 crore in the quarter ended September 2022 as against Rs 21.03 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales24.1721.03 15 OPM %8.906.37 -PBDT1.450.69 110 PBT1.030.30 243 NP0.780.02 3800

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Oct 11 2022 | 2:09 PM IST

Next Story